Clinical trial Recruiting at 1 site Interventional Ages 19 to 70

Patient-controlled remimazolam sedation under spinal anesthesia for hip replacement

Official title: Patient-controlled Remimazolam Sedation During Primary Hip Arthroplasty Under Spinal Anesthesia: an Open-Label Randomized Controlled Trial

Run by Seoul National University Hospital · NCT07661810 · Data updated 2026-11-12

In adults having hip replacement with spinal anesthesia, this study tests whether letting patients control their own sedation with remimazolam works as well as standard clinician-controlled sedation.

Quick facts

Study typeInterventional
Ages19 Years to 70 Years
SexAll
Enrollment104 (estimated)
SponsorSeoul National University Hospital
Academic / other
Locations1 site (Seoul)
StatusRecruiting
StartedOctober 26, 2026
Main results expectedApril 30, 2027
Study endsMay 31, 2027
Registry record updatedNovember 3, 2026
Trial IDNCT07661810 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 19–70 undergoing primary hip arthroplasty with ASA I–II and eligible for spinal anesthesia.

Probably not a fit

Patients not achieving adequate sedation with self-titration or those with contraindications to remimazolam may derive no benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial compares patient-controlled sedation (PCS) to clinician-controlled sedation (CCS) using remimazolam in adults undergoing primary hip arthroplasty with spinal anesthesia. Participants are randomly assigned to PCS or CCS, with a defined initial dose for PCS and the option for patients to self-titrate as needed. Outcomes include total remimazolam use, depth of sedation, sedation-related adverse events, airway interventions, and satisfaction of patients and surgeons. The study aims to see if PCS can reduce drug consumption without compromising effective sedation. Secondary monitoring will assess safety and user experience.

Why it matters

Potential benefit: If successful, PCS could reduce total sedative exposure and potentially improve patient control and satisfaction during hip replacement anesthesia.

How similar studies have gone: Previous research in other settings suggests patient-controlled anesthesia can reduce drug use while maintaining comfort, but results vary by drug and procedure.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged 19 to 70 years with an ASA (American Society of Anesthesiologists) physical status of I or II who are undergoing primary hip arthroplasty under spinal anesthesia.

Exclusion Criteria:

* Refusal to participate in the study
* Patients with contraindications to spinal anesthesia
* Patients who do not consent to intraoperative sedation
* Patients with contraindications to remimazolam
* Patients with a history of allergy or hypersensitivity to remimazolam
* Patients with a baseline MOAA/S (Modified Observer's Assessment of Alertness/Sedation) score of 4 or lower
* Pregnant women

Where it's running

  • Seoul National University Hospital
    Seoul, South Korea
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.